HIV Clinical Trials
101 studies are recruiting for hiv in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
By city
Studies, page 2
-
Small Trial of Alendronate Impact on the Reservoir of HIV
This clinical trial is designed to test the effects of alendronate (ALN) on people living with HIV who are already receiving antiretroviral therapy (ART). Participants are randomly assigned in a 2:1 ratio to either receive alendronate or a placebo, and neither the participants nor the researchers k…
- Stage
- Phase 2
- Ages
- 18 to 65
- Site
- University of California, San Francisco HIV/AIDS (Site ID: 801), San Francisco, California
- Locations
- 5 in total
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
-
Bridge to Belonging: Peer Led Intervention to Reduce Loneliness and Depression Among Older Gay and Bisexual Men
Older gay and bisexual men living with HIV (OGBMLH) are more likely to experience depression and loneliness, which can lead to negative health outcomes. This mixed-methods research study will assess the feasibility and acceptability of the Bridge to Belonging (B2B) intervention. B2B is a peer-deliv…
- Stage
- Not phased
- Ages
- 50 and older
- Site
- Fenway Health, Boston, Massachusetts
- Run by
- Fenway Community Health
-
High-Intensity Exercise to Combat Vascular and Cognitive Dysfunction in Adults With HIV
This is a single site, randomized exercise trial with individuals at least 50 years of age living with HIV who experience suboptimal cognition. The overall goals of this proposal are to determine whether 16 weeks of structured high-intensity interval training (HIIT) can overcome vascular and cognit…
- Stage
- Not phased
- Ages
- 50 and older
- Site
- University of Alabama at Birmingham, Birmingham, Alabama
- Run by
- University of Alabama at Birmingham
-
Optimization of a Behavioral Intervention to Increase Physical Activity in Older Adults Living With HIV
The goal of this clinical trial is to examine 3 interventions designed to increase physical activity in older adults with HIV. We will examine 3 potential components of an intervention package: physical activity coaching, cognitive behavioral therapy targeted toward common barriers to physical acti…
- Stage
- Not phased
- Ages
- 50 and older
- Site
- Hennepin Healthcare Research Institute, Minneapolis, Minnesota
- Locations
- 2 in total
- Run by
- Butler Hospital
-
Bringing Medicines for HIV Prevention to a Family Planning Clinic
The goal of this clinical trial is to understand what patients and physicians think about providing medications to prevent HIV transmission to patients in a family planning clinic. These medications are known as pre-exposure prophylaxis, or PrEP. The main questions to answer are: 1. Do patients fin…
- Stage
- Not phased
- Ages
- 16 and older
- Site
- Women and Infants Hospital of Rhode Island, Providence, Rhode Island
- Run by
- Women and Infants Hospital of Rhode Island
-
Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA in Adult Participants Without HIV
This is a phase 1, multicenter, open-label, dose escalation, first-in-human (FIH) trial to evaluate the safety and immunogenicity of DV201P-RNA and DV202B1-RNA, immunogens designed to induce HIV-1 envelope (Env) V2 apex-specific broadly neutralizing antibodies (V2 apex bnAbs). Both vaccines consist…
- Stage
- Phase 1
- Ages
- 18 to 55
- Site
- The Ponce de Leon Center CRS (Site ID 5802), Atlanta, Georgia
- Locations
- 7 in total
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
-
BIG Chicago: A Trial of Basic Income Guarantee for Young People Living With HIV
The goal of this clinical trial is to compare two interventions - Basic Income Guarantee (BIG) + Treatment as Usual and Treatment as Usual among individuals living with HIV who have experienced financial hardships. The main question it aims to answer is: Compared with the Treatment as Usual group, …
- Stage
- Not phased
- Ages
- 18 to 35
- Site
- University of Chicago, Chicago, Illinois
- Run by
- University of Chicago
-
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
This is a phase 2, open-label study to assess the immunogenicity of the 9-valent human papillomavirus (HPV) recombinant vaccine (Gardasil9) in people born male with current or past exposure to androgen blockers or estrogen (BM-EABE). Investigators will enroll BM-EABE with HIV and HIV negative contr…
- Stage
- Phase 2
- Ages
- 18 to 70
- Site
- RIIS Clinic at Baltimore Safe Haven, Baltimore, Maryland
- Locations
- 2 in total
- Run by
- University of Maryland, Baltimore
-
Human Immunodeficiency Virus (HIV) Food Insecurities
The objectives of this study are to better understand how FI (food insecurities) contributes to the development of cardiometabolic comorbidities among PWH (People with HIV) and to test a novel bilingual FI intervention designed to reduce these comorbidities among food insecure PWH. The PI and staff…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Wake Forest Health Sciences, Winston-Salem, North Carolina
- Run by
- Wake Forest University Health Sciences
-
Case Management Dyad
The overall goal of this study is to test whether dyadic and focused case management will (1) improve financial wellbeing, (2) improve access to food, (3) increase linkage and retention rates for individuals living with HIV or those taking PrEP (PrEP persistence), and (4) increase the proportion of…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Chicago, Chicago, Illinois
- Run by
- University of Chicago
-
Alcohol and "Heat of the Moment" Sexual Decision Making
HIV transmission remains a significant public health concern, especially among men who have sex with men (MSM). Condomless anal intercourse (CAI) continues to be the major route of transmission for MSM. Thus, to reduce the incidence of HIV, it is critical to identify how contextual risk factors inf…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Boston University Department of Psychological and Brain Sciences, Boston, Massachusetts
- Run by
- Boston University Charles River Campus
-
Cabotegravir-Hormone PK/PD Interactions for HIV Prevention
This is a research study to better understand how long-acting cabotegravir (CAB-LA) works to prevent HIV in people. This study will also evaluate the impact of endogenous and therapeutic hormones on CAB-LA pharmacology. The investigators will also evaluate if participants experience any medical pro…
- Stage
- Phase 1
- Ages
- 19 and older
- Site
- Johns Hopkins School of Medicine, Drug Development Unit, Baltimore, Maryland
- Run by
- Johns Hopkins University
-
Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain
The purpose of this research study is to test whether Brief Behavioral Treatment for Insomnia (BBTI) delivered over the phone or Brief Mindfulness Training (BMT) delivered over the phone is better able to improve the symptoms of insomnia, reduce chronic pain, and slow the pace of biological aging i…
- Stage
- Not phased
- Ages
- 25 to 65
- Site
- Washington University School of Medicine, St Louis, Missouri
- Run by
- Washington University School of Medicine
-
The Neural Underpinnings of Depression and Cannabis Use in Young People Living With HIV
To elucidate mechanisms of substance use disorders (SUD) and comorbid mental illnesses in people living with HIV (PLWH), the study team seeks to investigate reward and pain circuitry in cannabis use and depression comorbidity, two highly prevalent conditions in PLWH. The study team proposes a tight…
- Stage
- Not phased
- Ages
- 18 to 59
- Site
- University of Miami, Miami, Florida
- Run by
- University of Miami
-
Practice Facilitation as a Strategy to Improve Alcohol Treatment Adoption and Implementation in HIV Care
Despite availability of evidence-based alcohol reduction interventions (EBI), unhealthy alcohol use remains a barrier to HIV medication adherence, viral suppression and retention in HIV care and consequently HIV treatment as prevention (TASP). Guided by complementary implementation and evaluation f…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of California, San Diego, San Diego, California
- Locations
- 3 in total
- Run by
- Johns Hopkins University
-
A Study to Improve Skeletal Muscle in Veterans With HIV
The Department of Veterans Affairs is the largest single provider of medical care to people with HIV in the United States. The condition of excess lipid within and around muscle, termed myosteatosis, predisposes Veterans to physical function decline, frailty, disability, and cardiometabolic disease…
- Stage
- Not phased
- Ages
- 20 to 80
- Site
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville, Tennessee
- Run by
- VA Office of Research and Development
-
Implementing Depression and Adherence Treatment
The goal of this clinical trial is to compare a core set and enhanced set of implementation strategies in increasing the reach of evidence-based treatments to patients with HIV and depression. The main questions it aims to answer are: What proportion of patients start an evidence-based treatment fo…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Miami, Miami, Florida
- Locations
- 3 in total
- Run by
- University of Miami
-
Mitigating the Impact of Stigma and Shame Among People Living With HIV and Substance Use Disorders
People living with HIV and substance use disorders (SUDs) are less likely to be virally suppressed, which can lead to HIV transmission and negative health outcomes. This hybrid type 1 study will assess the efficacy, mechanisms, as well as facilitators and barriers to implementing the MATTER interve…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Florida International University, Miami, Florida
- Locations
- 2 in total
- Run by
- Boston University
-
Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
This research is being done to better understand rejection in transplant recipients with HIV who receive kidneys from donors with vs without HIV.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Alabama at Birmingham, Birmingham, Alabama
- Locations
- 18 in total
- Run by
- Johns Hopkins University
-
Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults
The use of behavioral intervention to reduce stimulant use and concurrent HIV sexual transmission risk.
- Stage
- Not phased
- Ages
- 16 to 24
- Site
- University of California, Los Angeles, Los Angeles, California
- Locations
- 2 in total
- Run by
- Westat
-
Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP
The investigators will conduct an optimization trial among N=256 PWID newly started on medication for opioid use disorder and Pre-Exposure Prophylaxis (PrEP) to assess the performance of four intervention components (Attention, Executive Functioning, Memory, and Information Processing) aimed at enh…
- Stage
- Phase 4
- Ages
- 18 and older
- Site
- APT Foundation, New Haven, Connecticut
- Run by
- University of Connecticut
-
RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry
Justice-involved individuals face disproportionately high rates of stimulant use disorder and HIV, along with disrupted access to HIV treatment and prevention services like ART and PrEP. Contingency management (CM) is the most effective intervention for stimulant use, but its use in justice-involve…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Yale University, New Haven, Connecticut
- Locations
- 2 in total
- Run by
- University of Texas Southwestern Medical Center
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
People living with HIV (PLWH) have a higher rate of post-traumatic stress disorder (PTSD) diagnosis than the general population. Comorbid PTSD is also associated with negative HIV-related health outcomes. Unfortunately, little outcome research has examined the usefulness of PTSD treatments for PTSD…
- Stage
- Not phased
- Ages
- 18 to 65
- Site
- Albert Einstein College of Medicine, The Bronx, New York
- Run by
- Montefiore Medical Center
-
Skeletal Muscle Energetics and Fatiguability in Older Individuals
The investigators are studying whether metabolic abnormalities in calf (leg) muscle in older people with and others without HIV are associated with decreased abilities to exercise.
- Stage
- Not phased
- Ages
- 60 to 90
- Site
- Johns Hopkins Hospital, Baltimore, Maryland
- Run by
- Johns Hopkins University
-
Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women
The purpose of this 2-site (CT, AL) study is to test innovative interventions to reduce stigma and improve the pre-exposure prophylaxis (PrEP) and opioid use disorder (OUD) care continua in women involved in the criminal justice system (WICJ). This study evaluates a newly validated PrEP decision ai…
- Stage
- Phase 4
- Ages
- 18 and older
- Site
- University of Alabama in Birmingham, Birmingham, Alabama
- Locations
- 2 in total
- Run by
- Yale University
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.